Has Raymond Steinmetz, MD received payments from drug or device companies?

Yes. Drug and device makers reported $64,360 in general payments to Raymond Steinmetz, MD across 270 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Raymond Steinmetz, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Raymond Steinmetz, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Raymond Steinmetz, MD

Orthopaedic Surgery · Oklahoma City, OKNPI 1265810733

Payments from drug & device makers

What this record shows

This record is dominated by education: $41,716 of the $64,360 with a category attached, or 64.8%. 15 manufacturers reported payments, led by Pylant Medical at 34.1% of the total. Reporting peaked in 2021 at $21,670 and has fallen 59.0% since, to $8,891 in 2025. Among orthopaedic surgery clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$64,360in general payments, 2019–2025

Across 270 payments — averaging $238.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pylant Medical$22K
Smith+Nephew$19K
Stryker$9K
Arthrex$8K
Elite Orthopedics, LLC$4K
Exactech, Inc.$1K
plus $1K from 9 others

What the payments were for

Consulting fees$1,5752%
Speaking & faculty fees$3,1505%
Travel & lodging$5,3858%
Food & beverage$12,53419%
Education$41,71665%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pylant Medical	29	$21,940
Smith+Nephew	44	$18,842
Stryker	134	$9,301
Arthrex	31	$7,594
Elite Orthopedics, LLC	6	$3,929
Exactech, Inc.	3	$1,494
Medical Device Business Services, Inc.	2	$639
Zimmer Biomet	2	$165
Johnson & Johnson	3	$164
Vericel Corporation	7	$140
Pacira Pharmaceuticals Incorporated	3	$59
Bioventus LLC	3	$40
Ultragenyx Pharmaceutical Inc.	1	$20
ERMI LLC	1	$17
Pacira Therapeutics, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MAKO$2,821
NA$1,575
Coblation$1,575
SPATIAL FRAME$1,575
EQUINOXE$1,494
Bioinductive Implant with Arthroscopic Delivery System - Medium$1,480
Mini-Open Latarjet$1,480
MICRORAPTOR$1,480
Q-FIX$1,480
AETOS Shoulder System$1,480
NOVOSTITCH PRO$840
REGENETEN Shoulder$577
Healicoil$563
ACCOLADE$487
REUNION$467
FAST-FIX FLEX$453
HEALICOIL PK Hip$453
Meniscal Root Repair System$453
GTS System$387
Coblator II$387

How this compares

$64,360 in reported general payments places this provider in the 90th percentile of 263 orthopaedic surgery providers in Oklahoma.

See all orthopaedic surgery providers in Oklahoma →

Medicare billing

Part B allowed, 2024

$67,800

Medicare patients

122

Services billed

987

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ondansetron OdtOndansetron	41	$373
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	41	$321
Etodolac	13	$265
Cyclobenzaprine Hcl	51	$216
Meloxicam	47	$151
Oxycodone Hcl	25	$128
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	16	$127
Tramadol Hcl	15	$40

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Oklahoma City

Andrew ParkinsonOklahoma City$3.1M
Bradley ReddickOklahoma City$573K
Jason EmersonOklahoma City$189K
Ronald DumiganOklahoma City$169K
Paul MaitinoOklahoma City$110K
Thomas TkachOklahoma City$83K
Brian LevingsOklahoma City$80K
Christopher WhiteOklahoma City$73K
Michael JohnsonOklahoma City$63K
Ryan NelsonOklahoma City$52K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →